200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 76932-56-4

76932-56-4

76932-56-4 | Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]-

CAS No: 76932-56-4 Catalog No: AG00392K MDL No:MFCD00871253

Product Description

Catalog Number:
AG00392K
Chemical Name:
Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]-
CAS Number:
76932-56-4
Molecular Formula:
C66H83N17O13
Molecular Weight:
1322.4713
MDL Number:
MFCD00871253
IUPAC Name:
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
InChI:
InChI=1S/C66H83N17O13/c1-36(2)25-48(58(89)76-47(13-7-23-71-66(68)69)65(96)83-24-8-14-54(83)64(95)73-33-55(67)86)77-60(91)50(28-38-15-18-39-9-3-4-10-40(39)26-38)78-59(90)49(27-37-16-19-43(85)20-17-37)79-63(94)53(34-84)82-61(92)51(29-41-31-72-45-12-6-5-11-44(41)45)80-62(93)52(30-42-32-70-35-74-42)81-57(88)46-21-22-56(87)75-46/h3-6,9-12,15-20,26,31-32,35-36,46-54,72,84-85H,7-8,13-14,21-25,27-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,90)(H,79,94)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71)/t46-,47-,48-,49-,50+,51-,52-,53-,54-/m0/s1
InChI Key:
RWHUEXWOYVBUCI-ITQXDASVSA-N
SMILES:
OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1ccc2c(c1)cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1
UNII:
1X0094V6JV

Properties

Complexity:
2730  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0
Exact Mass:
1321.636g/mol
Formal Charge:
0
Heavy Atom Count:
96  
Hydrogen Bond Acceptor Count:
15  
Hydrogen Bond Donor Count:
16  
Isotope Atom Count:
0
Molecular Weight:
1322.496g/mol
Monoisotopic Mass:
1321.636g/mol
Rotatable Bond Count:
33  
Topological Polar Surface Area:
475A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.8  

Literature

Title Journal
Development of semen quality following reversible downregulation of testicular function in male dogs with a GnRH agonist implant. Reproduction in domestic animals = Zuchthygiene 20120801
Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality. Archives of gynecology and obstetrics 20120201
A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis. Journal of women's health (2002) 20110401
Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists. Clinical therapeutics 20100901
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. BJOG : an international journal of obstetrics and gynaecology 20100601
Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. Theriogenology 20100415
Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis. Archives of gynecology and obstetrics 20090701
Controlled delivery of a GnRH agonist by a silastic implant (Gonazon) results in long-term contraception in queens. Reproduction in domestic animals = Zuchthygiene 20090701
Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant. Reproduction in domestic animals = Zuchthygiene 20090701
Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant 'Gonazon'; a preclinical trial. Theriogenology 20090415
Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy. BJOG : an international journal of obstetrics and gynaecology 20090401
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 20090401
[Application of Pfizer drugs in the obstetrics and gynecology practice]. Akusherstvo i ginekologiia 20090101
Endometriosis can evade diagnosis. RN 20080901
Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review. Sao Paulo medical journal = Revista paulista de medicina 20080901
[Some possibilities for application of 'Pfizer' medicines--Prostin 15m, Prostin E2, Prepidil gel, Dostinex, Synarel--in the obstetrician practice]. Akusherstvo i ginekologiia 20070101
Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. Theriogenology 20061001
A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Human reproduction (Oxford, England) 20061001
[Endometriosis]. Nihon rinsho. Japanese journal of clinical medicine 20060401
[In vitro fertilization and embryo transfer]. Nihon rinsho. Japanese journal of clinical medicine 20060401
A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Human reproduction (Oxford, England) 20060101
Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study. Reproductive biomedicine online 20060101
Danazol treatment of endometriosis-associated pain. Journal of minimally invasive gynecology 20060101
GnRH analogs: options for endometriosis-associated pain treatment. Journal of minimally invasive gynecology 20060101
Autoimmune progesterone dermatitis: a rare pathology. European journal of obstetrics, gynecology, and reproductive biology 20051101
A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan. Journal of the Chinese Medical Association : JCMA 20050701
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatment. The journal of obstetrics and gynaecology research 20040401
Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040401
Delivery and stability of LHRH and Nafarelin in human skin: the effect of constant/pulsed iontophoresis. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040201
Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle. European journal of obstetrics, gynecology, and reproductive biology 20040115
Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles. Reproductive biology and endocrinology : RB&E 20040101
Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 20031101
[Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity]. Ginekologia polska 20031001
Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa-response in relation to chromosome karyotype. European journal of obstetrics, gynecology, and reproductive biology 20030910
Chronic treatment with an agonist of gonadotropin-releasing hormone enhances luteal function in cattle. Biology of reproduction 20030801
Membrane activity of biotechnological peptide drugs. Chemical communications (Cambridge, England) 20030621
The administration of the GnRH antagonist, cetrorelix, to ooctye donors simplifies oocyte donation. Human reproduction (Oxford, England) 20030601
Effect of chronic treatment with the gonadotrophin-releasing hormone agonist azagly-nafarelin on basal concentrations of LH in prepubertal bulls. Reproduction (Cambridge, England) 20030201
The serum concentration of estradiol after embryo transfer and the decline from preovulatory levels may influence the success of IVF treatment. Hormone research 20030101
In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome. Human reproduction (Oxford, England) 20021001
Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study. European journal of obstetrics, gynecology, and reproductive biology 20020710
Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density? The Journal of reproductive medicine 20020701
[Comparative study of the efficiency of gonadotrope releasing hormone (GnRH) analogs for the treatment of endometriosis]. Orvosi hetilap 20020616
Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20020201
The case of the elusive androgen. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101
Acute exacerbation of chronic maxillary sinusitis during therapy with nafarelin nasal spray. European journal of obstetrics, gynecology, and reproductive biology 20011201
Prospective randomized comparison of ovarian blockade with nafarelin versus leuprolide during ovarian stimulation with recombinant FSH in an ICSI program. Journal of assisted reproduction and genetics 20011101
A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection. Fertility and sterility 20010901
Utero-ovarian blood flow characteristics of pituitary desensitization. Human reproduction (Oxford, England) 20010801
Changes in quality of life after hormonal treatment of endometriosis. Acta obstetricia et gynecologica Scandinavica 20010701
Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilisation treatment. Journal of assisted reproduction and genetics 20010601
[Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis]. Ginekologia polska 20010501
Medical and surgical therapies for pain associated with endometriosis. Journal of women's health & gender-based medicine 20010301
[Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin]. Gynecologie, obstetrique & fertilite 20010201
Efficacy of nafarelin in assisted reproductive technology: a meta-analysis. Human reproduction update 20010101
Hormonal therapy for the subfertility of cryptorchidism. Hormone research 20010101
Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Human reproduction update 19980101
Uses of GnRH agonists. Journal of obstetric, gynecologic, and neonatal nursing : JOGNN 19940901
Nafarelin in the management of endometriosis: quality of life assessment. American journal of obstetrics and gynecology 19920201
Gonadotropin-releasing hormone analogs: update on new findings. American journal of obstetrics and gynecology 19920201
Pharmacologic management of endometriosis. Clinical pharmacy 19910701
Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis. DICP : the annals of pharmacotherapy 19901201
Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions. Drugs 19900401

© 2019 Angene International Limited. All rights Reserved.